Background Recent research suggests that the incidence of inflammatory bowel disease (IBD) in the UK is 1 in every 123 people, and that previously these numbers have been largely underestimated.
Colorectal cancer background and risk factors Colorectal (or bowel) cancer (CRC) is cancer anywhere in the colon (the large intestine) or the rectum.
DiaSys successfully introduced Total bile acids 21 FS to determine total bile acids (TBA) in serum. Now, without altering the reagent composition and the highly sensitive enzymatic cycling method, the scope of the test has been expanded to detect TBA in human stool samples.
by Dr Jacqueline Gosink In 2022, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published a position paper on the management and follow-up of children and adolescents with coeliac disease (CD), following publication of new guidelines for the diagnosis of CD in 2020. This article discusses the different markers that can be used […]
by Dr Jingmei Lin and Dr Rong Fan Cytomegalovirus infection in the gastrointestinal tract likely occurs in periods of immunosuppression. The diagnosis of cytomegalovirus infection in the gastrointestinal tract can be made in several ways including serology, testing for viremia, viral culture from biopsy material, histopathologic examination coupled with immunohistochemistry, and molecular method […]
by Dr Petraki Munujos The anti-parietal cell antibodies show one of the most distinctive fluorescent patterns in the autoantibody screening by indirect immunofluorescence. Although these antibodies react with a well known target antigen (H+/K+ ATPase) solely present in the parietal cells of the gastric gland, the use of combined tissue sections in the same reaction […]
by Dr Hetty J. Bontkes
Type II refractory celiac disease (RCD-II) and enteropathy associated T-cell lymphoma (EATL) are rare but serious complications of adult onset celiac disease.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
